Summary by Futu AI
Conduit Pharmaceuticals Inc. has filed a registration statement on Form S-8 with the Securities and Exchange Commission (SEC) on January 10, 2024. This filing registers an additional 3,691,476 shares of common stock that may be issued under the company's 2023 Stock Incentive Plan. The plan includes an automatic annual increase in the number of shares available for issuance, which will occur on the first day of each fiscal year starting January 1, 2024, and will continue through January 2033. The increase is the lesser of 5% of the outstanding common stock at the end of the preceding fiscal year or a smaller number determined by the board of directors or its Compensation Committee. The newly registered shares are a result of this 'Plan Evergreen Provision'. Previously, up to 11,497,622 shares were registered under a prior Form S-8 filed on December 1, 2023. The contents of the prior registration statement are incorporated by reference into this new registration statement, which includes only new information not previously disclosed.